Zeev Nitsan

Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

Ana Westenberger, Volha Skrahina, Tatiana Usnich et al. · Brain · 2024 · 89 citations · Full text

Life Sciences, Genetics, Neurology +15

The <i>LRRK2</i> G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers

Rivka Inzelberg, Ohad Cohen, J. Aharon‐Peretz et al. · Neurology · 2012 · 67 citations

Life Sciences, Genetics, Oncology +17

Familial Creutzfeldt–Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD

Oren S. Cohen, Joab Chapman, Amos D. Korczyn et al. · Journal of Neurology · 2014 · 56 citations

Medicine, Genetics, Neurology +8

Repetitive Deep TMS for Parkinson Disease: A 3-Month Double-Blind, Randomized Sham-Controlled Study

Oren S. Cohen, Amihai Rigbi, Gilad Yahalom et al. · Journal of Clinical Neurophysiology · 2018 · 49 citations

Medicine, Neurology, Neuroscience +16

Plasma Homocysteine Levels and Parkinson Disease

Sharon Hassin‐Baer, Oren S. Cohen, Eli Vakil et al. · Clinical Neuropharmacology · 2006 · 47 citations

Medicine, Neurology, Neuroscience +16